Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The mRNA expression profiles from glioblastoma cells residing at the tumor core and invasive rim of a human tumor resection were compared. From a single tumor specimen, 20,000 single cells from each region were collected by laser capture microdissection. Differential expression of 50-60 cDNA bands was detected. One of the sequences overexpressed by the invasive cells showed 99% homology to the
P311
gene, the protein product of which is reported to localize at focal adhesions. Relative overexpression of
P311
by invading glioblastoma cells compared with tumor core was confirmed by quantitative reverse transcription-PCR of six glioblastoma specimens after laser capture microdissection collection of rim and core cells. In vitro studies using antisense oligodeoxynucleotides and integrin activation confirmed the role of
P311
in supporting migration of malignant
glioma
cells. Immunochemistry studies confirmed the presence of the
P311
protein in tumor cells, particularly at the invasive edge of human glioblastoma specimens.
...
PMID:Identification and validation of P311 as a glioblastoma invasion gene using laser capture microdissection. 1135 44
P311
, an 8-kDa polypeptide, was previously shown to be highly expressed in invasive
glioma
cells. Here, we report the functional characteristics of
P311
with regard to influencing
glioma
cell migration.
P311
is constitutively serine-phosphorylated; decreased phosphorylation is observed in migration-activated
glioma
cells. The primary amino acid sequence of
P311
indicates a putative serine phosphorylation site (S59) near the PEST domain. Site-directed mutagenesis of S59A retarded
P311
degradation and induced
glioma
cell motility. In contrast, S59D mutation resulted in the rapid degradation of
P311
and reduced
glioma
cell migration. Coimmunoprecipitation coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis identified Filamin A as a binding partner of
P311
, and immunofluorescence studies showed that both proteins colocalized at the cell periphery. Moreover,
P311
-induced cell migration was abrogated by inhibition of beta1 integrin function using TACbeta1A, a dominant-negative inhibitor of beta1 integrin signaling, suggesting that
P311
acts downstream of beta1 signaling. Finally, overexpression of
P311
or
P311
S59A mutant protein activates Rac1 GTPase; small interfering RNA-mediated depletion of Rac1 suppresses
P311
-induced motility. Collectively, these results suggest a role for levels of
P311
in regulating
glioma
motility and invasion through the reorganization of actin cytoskeleton at the cell periphery.
...
PMID:Regulation of glioma cell migration by serine-phosphorylated P311. 1622 9
We have previously reported the presence of Dlxin-1, a member of the melanoma antigen gene (MAGE) family, in the brain and showed its function as a cell cycle arrest protein, suggesting that Dlxin-1 may have anti-proliferative functions in rapidly growing tumors. Using the cancer stem cell hypothesis, which attributes the initiation and progression of brain tumors to the cancer-initiating stem cells, we have investigated the role of Dlxin-1 in the
glioma
stem cells propagated by us as a cell culture system comprising of HNGC-2 cells. Our studies provide evidence about the role of Dlxin-1 as an anti-tumorigenic protein in the highly chemo-resistant
glioma
stem cells. Next, we show that these anti-proliferative effects are manifested by Dlxin-1 through down regulation of the activities of MMP-2 and MMP-9, and through interaction of Dlxin-1 with its target protein
P311
that is involved in
glioma
cell invasion. In summary, we establish the roles for Dlxin-1, one as an anti-tumorigenic and anti-invasive protein in high-grade gliomas and the other as an inducer of differentiation of
glioma
stem cells. These two attributes, in conjunction, result in conversion of the drug-resistant brain tumor stem cells to the tumor-attenuated cells that may now be more amenable to effective therapeutic targeting.
...
PMID:Dlxin-1, a member of MAGE family, inhibits cell proliferation, invasion and tumorigenicity of glioma stem cells. 2110 81